Company intelligence / Profile preview

Parabolic Drugs

Chandigarh, Chandigarh, India

Ownership: Private
Development stage: Other

Overview

Parabolic Drugs was primarily an API and intermediate manufacturer focused on the antibiotic segment, specifically cephalosporins and semi-synthetic penicillins. The company has faced significant financial distress and was admitted into the Corporate Insolvency Resolution Process (CIRP).

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Parabolic Drugs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parabolic Drugs.

Explore the full profile